Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,89%
1 083,04
-9,76
-0,89%
—1 092,801 093,681 094,851 081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,39%
602,38
-2,36
-0,39%
—604,74604,74605,10601,34——
SIXE
Energy
SIXE
Energy
SIXE
+2,31%
1 242,83
+28,03
+2,31%
—1 214,801 220,811 243,821 220,81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,62%
1 713,82
-10,75
-0,62%
—1 724,571 727,021 732,301 707,43——
SIXM
Financials
SIXM
Financials
SIXM
+0,09%
639,99
+0,56
+0,09%
—639,43641,58644,53637,50——
SIXR
Staples
SIXR
Staples
SIXR
-0,20%
837,46
-1,69
-0,20%
—839,15836,90840,48832,89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,65%
214,22
-1,40
-0,65%
—215,62215,62216,21213,48——
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3 204,38
+24,86
+0,78%
—3 179,523 191,503 205,093 177,75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,23%
925,38
-11,53
-1,23%
—936,91935,42937,17923,20——
SIXV
Health care
SIXV
Health care
SIXV
-0,69%
1 442,71
-10,06
-0,69%
—1 452,771 445,931 447,431 434,91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,16%
2 361,34
-3,84
-0,16%
—2 365,182 353,642 368,102 347,80——
CMPS:NASDAQ
Compass Pathways PLC
8,38 US$
-0,71%
(-0,060) 1K
8,63 US$
+2,98% (+0,25)
Birjadan oldin
Savdolar yopilgan: 29-apr, 16:00:01 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
CMPS tikeri uchun statistika yaratilmoqda...
Ochish
8,45 US$
Yuqori
8,57 US$
Past
8,25 US$
Bozor kapitali
1,13 mlrd
Oʻrtacha hajm
3,76 mln
Hajmi
2,36 ming
52 haftalik eng yuqori
10,21 US$
52 haftalik eng past
2,25 US$
Aksiya boʻyicha daromad
-3,08 US$
Beta
2,01
Muomaladagi aksiyalar
134,92 mln
Xodimlar soni
156
Yangiliklar
Internetdagi manbalardan
Profil
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin, is currently in phase 3 clinical trials for treatment-resistant depression. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration. It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine. Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder New Drug Application, Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus. Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wikipedia
Compass Pathways PLC haqida
CEO-
Xodimlar soni156
Asos solingan13-iyn, 2016
Bosh ofislar-
Sektor-
Veb-saytcompasspathways.com
Keyingi hisobot: 7 kundan keyin
Pay, 7-may, 08:00
Moliya davri
Ch.1 2026
Normallashtirilgan EPS / Taxminiy
-/ (-0,32 taxm.)USD
Daromad / Taxminan
-/ (0,00 taxm.)USD
Q1 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha: kelgusi tushumlarOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
-
-
-
-
Sotilgan mahsulotning tannarxi
-
-
-
-
Daromad narxi
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar
22,43 mln
26,04 mln
23,40 mln
42,82 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
18,74 mln
12,61 mln
13,21 mln
16,05 mln
Operatsion xarajatlar
41,17 mln
38,65 mln
36,61 mln
58,86 mln
Jami operatsion xarajatlar
41,17 mln
38,65 mln
36,61 mln
58,86 mln
Operatsion daromad
-41,17 mln
-38,65 mln
-36,61 mln
-58,86 mln
Boshqa nooperatsion daromad
20,26 mln
-2,72 mln
-100,94 mln
-37,79 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-17,51 mln
-38,27 mln
-137,95 mln
-96,61 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-17,51 mln
-38,27 mln
-137,95 mln
-96,61 mln
Daromad soligʻi boʻyicha xarajat
354,00 ming
137,00 ming
-230,00 ming
-2,73 mln
Amaldagi soliq stavkasi
-2,02%
-0,36%
0,17%
2,83%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-17,86 mln
-38,40 mln
-137,72 mln
-93,88 mln
Sof foyda marjasi
-
-
-
-
Har bir aksiya foydasi
-0,42
-0,41
-0,38
-0,61
Foizlar va investitsiyalardan olingan daromadlar
2,39 mln
1,90 mln
1,59 mln
1,31 mln
Foizlarni toʻlash xarajatlari
-1,12 mln
-1,15 mln
-1,10 mln
-1,14 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
1,26 mln
747,00 ming
483,00 ming
173,00 ming
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-41,13 mln
-38,49 mln
-36,60 mln
-58,86 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish